M08.028.003 Myasthenic syndromes

Myasthenic syndromes encompass a group of neuromuscular disorders characterized by muscle weakness. This section delves into the two most common forms encountered in clinical practice: Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS). Understanding their pathogenesis, clinical presentations, and treatment modalities is essential for medical students.

Myasthenia Gravis (MG)

Description:

• Autoimmune disease targeting the acetylcholine (ACh) receptor at the neuromuscular junction (NMJ).
• Autoantibodies block or destroy ACh receptors, hindering neuromuscular transmission and causing muscle weakness.
• Females are more commonly affected than males.

Clinical Features:

• Predominantly affects ocular muscles:
  • Ptosis (drooping eyelid).
  • Diplopia (double vision) due to weakness of extraocular muscles.
• Muscle weakness worsens with repeated contractions (e.g., difficulty climbing stairs, chewing).
• Severe cases: Respiratory muscle weakness can be life-threatening.
• Association with thymus:
  • Thymic hyperplasia (enlarged thymus) is observed in some MG patients.
  • Thymomas (tumors of the thymus) can also occur.

Treatment:

• Anticholinesterase medications: Enhance ACh availability at the NMJ, improving muscle contraction. (e.g., pyridostigmine)
• Immunosuppressive therapy: Suppresses antibody production and reduces autoimmune attack on ACh receptors. (e.g., corticosteroids)
• Thymectomy: Surgical removal of the thymus can be beneficial in some MG patients, particularly those with thymic hyperplasia.

Table 1. Summary of Myasthenia Gravis Characteristics

Points to Remember:

• MG is a chronic condition requiring long-term management.
• Early diagnosis and treatment are crucial to prevent complications and improve quality of life.

Image:

Bibliography:

• National Institute of Neurological Disorders and Stroke: https://www.ncbi.nlm.nih.gov/books/NBK559331/

Lambert-Eaton Myasthenic Syndrome (LEMS)

Description:

• Autoimmune disorder targeting presynaptic voltage-gated calcium channels at the NMJ.
• Autoantibodies disrupt calcium influx into the presynaptic terminal, hindering ACh release and causing muscle weakness.
• Often precedes the diagnosis of small-cell lung cancer.

Clinical Features:

• Proximal muscle weakness: Affects muscles closer to the body’s core (e.g., thighs, hips).
• Dry mouth: A characteristic symptom due to autonomic nervous system involvement.
• Autonomic dysfunction: Can manifest as postural hypotension (dizziness upon standing).

Treatment:

• Immunotherapy: Plasma exchange or intravenous immune globulin to suppress antibody production.
• Cancer treatment: If LEMS is associated with small cell lung cancer, addressing the underlying malignancy is crucial.

Table 2. Summary of Lambert-Eaton Myasthenic Syndrome Characteristics

Points to Remember:

• LEMS is a paraneoplastic syndrome, often associated with underlying cancer.
• Early detection of the associated malignancy is essential for optimal management.